Evaluation of pre-dose and post-dose anti-factor Xa levels with enoxaparin use during pregnancy

Trial Profile

Evaluation of pre-dose and post-dose anti-factor Xa levels with enoxaparin use during pregnancy

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2013

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Jan 2008 Planned patients number changed from 20 to 15 as reported by ClinicalTrials.gov.
    • 14 Jan 2008 Status changed from recruiting to completed.
    • 09 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top